Perinatal depression and anxiety: Clinical sciences

Last updated: January 30, 2025

Perinatal depression and anxiety: Clinical sciences

Topics for Physical Assessment

Topics for Physical Assessment

Approach to skin and soft tissue lesions: Clinical sciences
Approach to skin and soft tissue infections: Clinical sciences
Approach to skin and soft tissue injury: Clinical sciences
Approach to common skin rashes: Clinical sciences
Approach to a rash in the well newborn and infant: Clinical sciences
Approach to viral exanthems (pediatrics): Clinical sciences
Herpes zoster infection (shingles): Clinical sciences
Approach to anxiety disorders: Clinical sciences
Approach to sleep disorders: Clinical sciences
Approach to mood disorders: Clinical sciences
Approach to trauma and stressor-related disorders: Clinical sciences
Approach to a fever (0-60 days): Clinical sciences
Approach to a fever (over 2 months): Clinical sciences
Approach to a fever: Clinical sciences
Approach to growth faltering: Clinical sciences
Approach to back pain: Clinical sciences
Approach to joint pain and swelling: Clinical sciences
Approach to hip pain: Clinical sciences
Approach to foot pain: Clinical sciences
Approach to ankle pain: Clinical sciences
Approach to shoulder pain: Clinical sciences
Approach to knee pain: Clinical sciences
Approach to common musculoskeletal injuries (pediatrics): Clinical sciences
Juvenile idiopathic arthritis: Clinical sciences
Legg-Calve-Perthes disease and slipped capital femoral epiphysis: Clinical sciences
Developmental dysplasia of the hip: Clinical sciences
Approach to headache or facial pain: Clinical sciences
Concussion and traumatic brain injury
Approach to dizziness and vertigo: Clinical sciences
Approach to altered mental status: Clinical sciences
Approach to involuntary movements: Clinical sciences
Approach to tremor: Clinical sciences
Approach to polyneuropathy: Clinical sciences
Approach to acute vision loss: Clinical sciences
Approach to a red eye: Clinical sciences
Approach to facial palsy: Clinical sciences
Approach to amblyopia and strabismus (pediatrics): Clinical sciences
Eyelid disorders: Clinical sciences
Approach to head and neck masses (pediatrics): Clinical sciences
Approach to leukocoria (pediatrics): Clinical sciences
Approach to diplopia: Clinical sciences
Approach to peripheral lymphadenopathy (pediatrics): Clinical sciences
Approach to peripheral lymphadenopathy: Clinical sciences
Upper respiratory tract infection
Upper respiratory tract infections: Clinical sciences
Otitis media and externa (pediatrics): Clinical sciences
Allergic rhinitis: Clinical sciences
Influenza: Clinical sciences
Pharyngitis, peritonsillar abscess, and retropharyngeal abscess (pediatrics): Clinical sciences
Croup and epiglottitis: Clinical sciences
Acute group A streptococcal infections and sequelae (pediatrics): Clinical sciences
Infectious mononucleosis: Clinical sciences
Approach to a cough (acute): Clinical sciences
Approach to a cough (subacute and chronic): Clinical sciences
Atelectasis: Clinical sciences
COVID-19: Clinical sciences
Asthma: Clinical sciences
Bronchiolitis: Clinical sciences
Community-acquired pneumonia: Clinical sciences
Chronic obstructive pulmonary disease: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Approach to a breast mass and asymmetry: Clinical sciences
Approach to breast pain (mastalgia): Clinical sciences
Approach to nipple discharge: Clinical sciences
Fibrocystic breast changes: Clinical sciences
Well-patient care (GYN): Clinical sciences
Cervical cancer screening: Clinical sciences
Approach to vulvar skin disorders: Clinical sciences
Approach to vaginal discharge: Clinical sciences
Sexually transmitted infection screening (GYN): Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to acute pelvic pain (GYN): Clinical sciences
Approach to dysmenorrhea: Clinical sciences
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Approach to adnexal masses: Clinical sciences
Approach to hypertension: Clinical sciences
Approach to a murmur (pediatrics): Clinical sciences
Approach to congenital heart diseases (cyanotic): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Atrial fibrillation and atrial flutter: Clinical sciences
Congestive heart failure: Clinical sciences
Approach to dyspnea: Clinical sciences
Approach to chest pain: Clinical sciences
Aortic stenosis: Clinical sciences
Mitral stenosis: Clinical sciences
Hypertrophic cardiomyopathy: Clinical sciences
Approach to lower limb edema: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Venous insufficiency and ulcers: Clinical sciences
Preconception care: Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Antepartum care (third trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (first trimester): Clinical sciences
Venous thromboembolism in pregnancy: Clinical sciences
Approach to upper abdominal pain: Clinical sciences
Approach to periumbilical and lower abdominal pain: Clinical sciences
Approach to constipation: Clinical sciences
Approach to constipation (pediatrics): Clinical sciences
Approach to abdominal wall and groin masses: Clinical sciences
Approach to chronic abdominal pain (pediatrics): Clinical sciences
Approach to vomiting (pediatrics): Clinical sciences
Approach to diarrhea (pediatrics): Clinical sciences
Approach to melena and hematemesis (pediatrics): Clinical sciences
Well-patient care (geriatrics): Clinical sciences
Approach to unsteadiness, gait disturbance, or falls: Clinical sciences
Approach to dysarthria or dysphagia: Clinical sciences
Approach to gradual cognitive decline: Clinical sciences
Osteoporosis: Clinical sciences
Testicular cancer: Clinical sciences
Testicular torsion (pediatrics): Clinical sciences
Benign prostatic hypertrophy and prostate cancer: Clinical sciences
Approach to perianal problems: Clinical sciences
Inguinal hernias: Clinical sciences
Approach to dysuria: Clinical sciences
Approach to urinary incontinence (GYN): Clinical sciences
Approach to proteinuria (pediatrics): Clinical sciences
Urinary retention: Clinical sciences
Lower urinary tract infection: Clinical sciences
Approach to fatigue: Clinical sciences
Approach to unintentional weight loss: Clinical sciences
Approach to weakness (focal and generalized): Clinical sciences
Approach to a fever in the returned traveler: Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Perinatal depression and anxiety are conditions that affect many pregnant and postpartum patients up to a year after childbirth. Depression can range from mild perinatal depression or “postpartum blues” to severe conditions with suicidal or infanticidal ideations, such as postpartum psychosis. Perinatal anxiety is often seen in combination with perinatal depression.

Keep in mind that, prior to making the diagnosis of a perinatal mental health condition, it’s important to consider and evaluate other medical conditions that could cause similar symptoms. These include thyroid dysfunction, severe anemia, medication side effects, and substance use. Screening for, diagnosing, and treating perinatal anxiety and depression is essential, as they’re associated with adverse maternal and fetal outcomes.

Your first step is to perform a safety assessment. Let’s first see what to do when there are safety concerns.

Start by asking your patient about symptoms of depression and anxiety.
You should also determine whether they have intrusive thoughts of harming themself or their baby, to the point where they’re comforted by those thoughts or feel as if acting on these thoughts will help the infant or society in general. Additional safety concerns include a lack of insight into whether their intrusive thoughts are based on reality; and if they have auditory or visual hallucinations or other bizarre beliefs that aren’t based on reality. If you notice any of these findings, the patient is considered unsafe.
This is an emergency and may indicate postpartum psychosis.

Start with acute management right away. Be sure not to alarm your patient, but don’t leave them or their baby alone while seeking help. Admit them to the hospital and seek emergent psychiatric consultation. Continue one-on-one monitoring to reduce the risk of suicide or infanticide.

Once you, your patient, and their baby are in a safe place, obtain a focused history and physical examination, which includes a mental status exam. Next, obtain labs to evaluate for conditions that can mimic postpartum psychosis. These include CBC, BMP, TSH, ammonia, and a toxicology screen to assess for alcohol, benzodiazepines, cocaine, or cannabis intoxication. You might also need to perform a lumbar puncture for CSF analysis. Additional testing might include brain imaging with an MRI, and an electroencephalogram or EEG.

Postpartum psychosis is rare but quite serious. History might reveal a sudden onset in the first 3 to 10 days postpartum, but it may present up to 4 weeks after delivery, or even longer. The biggest risk factors are having bipolar disorder or having had a previous history of postpartum psychosis or mania, but keep in mind that most patients with postpartum psychosis don’t have a significant mental health history.

On mental status exam, they may appear agitated and experience delusions, disorganized thoughts, or bizarre behavior. They may also experience auditory or visual hallucinations and have intrusive thoughts of suicide or infanticide. Finally, they’ll have limited or no insight into these symptoms, which are typically very different from their usual level of function.

If you see these findings in the setting of normal labs, imaging, and EEG, diagnose postpartum psychosis. Treatment requires psychiatric hospitalization, along with a multidisciplinary approach to care. Sleep preservation is important, so the patient might need to stop overnight breastfeeding. Most patients will require pharmacotherapy in the form of antipsychotics or benzodiazepines. You might also need to consider electroconvulsive therapy.

Keep in mind that these patients need continuous observation and psychiatric care. If treatment is initiated quickly and appropriately, full remission can be seen within 2 months.

Now let's go all the way back to our safety assessment. Patients who don’t present with concerns on safety assessment are considered safe. In this case, start with a focused history and physical examination, which includes a mental status exam. You’ll also need to use a validated tool to screen for depression, anxiety, and bipolar disorder. These include the Edinburgh Postnatal Depression Scale, or EPDS; the Patient Health Questionnaire 9, or PHQ-9; the General Anxiety Disorder-7, or GAD-7; and the Composite International Diagnostic Interview, or CIDI. The EPDS is most often used during pregnancy and postpartum because it screens for both depression and anxiety and includes a question about self-harm.

Time for a couple of clinical pearls! Perinatal depression and anxiety are common, so you should screen for these conditions periodically starting at the first prenatal visit, during the third trimester, and again postpartum. Screening for bipolar disorder only needs to occur once perinatally, and should also be done before starting medication for perinatal depression.

Additionally, if at any point, your patient has a positive response to a self-harm question during screening, provide appropriate mental health referrals. If the patient endorses suicidal ideation with intent and/or plan, immediately transfer them for an emergency psychiatric evaluation.

If your patient has a negative screen for depression, anxiety, and bipolar disorder, consider an alternative diagnosis.

On the flip side, if the EPDS or PHQ-9 screen is positive, suspect perinatal depression.

This condition typically occurs within the first 2 days up to 2 weeks after delivery. On the mental status exam, your patient may report a dysphoric mood, crying, mood lability, anxiety, sleeplessness, loss of appetite, or irritability. With these findings, diagnose mild perinatal depression, also known as “postpartum blues” or “baby blues”.

Symptoms generally resolve on their own without treatment, so management is focused on supportive care and close follow-up to ensure the symptoms have resolved. If symptoms persist for more than 1 to 2 weeks, or become worse and interfere with daily activities, you’ll need to evaluate for further mental health conditions.

Now let’s move on to perinatal depression.
In this case, your patient will present either during pregnancy or within the first 12 months after delivery. They’ll have at least 2 weeks of depressed mood or loss of interest, and four or more additional symptoms including weight gain or loss, insomnia or hypersomnia, psychomotor agitation, fatigue, feelings of worthlessness or guilt, concentration issues, or suicidal ideation.

Sources

  1. "Practice Advisory: Zuranolone for the Treatment of Postpartum Depression. January 30, 2024." ACOG
  2. "ACOG clinical practice guideline no 4. Screening and diagnosis of mental health conditions during pregnancy and postpartum. " Obstet Gynecol. (2023;141(6):1232-1261.)
  3. "ACOG clinical practice guideline no 5. Treatment and management of mental health conditions during pregnancy and postpartum. " Obstet Gynecol. (2023;141(6):1262-1288. )
  4. "Beckmann and Ling’s Obstetrics and Gynecology. 9th ed. " Wolters Kluwer; (2023. )